» Articles » PMID: 34249964

Exosomal MicroRNA-181a Derived From Mesenchymal Stem Cells Improves Gut Microbiota Composition, Barrier Function, and Inflammatory Status in an Experimental Colitis Model

Overview
Specialty General Medicine
Date 2021 Jul 12
PMID 34249964
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cell (MSC)-derived exosomes (Exos) are recently proved to be a promising candidate for ulcerative colitis (UC), but the mechanism remains unclear. We investigated the effects of MSC-derived exosomal microRNA-181a (miR-181a) on gut microbiota, immune responses, and intestinal barrier function in UC. Human bone marrow MSC-derived Exos were extracted and identified transmission electron microscopy (TEM), Nanoparticle Tracking Analysis (NTA), and Western blotting. Dextran sodium sulfate (DSS)-induced colitis model and lipopolysaccharide (LPS)-induced human colonic epithelial cell (HCOEPIC) model were established to determine the effect of MSC-Exos on gut microbiota, immune responses, and intestinal barrier function and . The relationship between miR-181a and UC was analyzed using the Gene Expression Omnibus (GEO) database. MSC-miR-181-inhibitor was used to reveal the role of exosomal miR-181a in DSS-induced colitis. TEM and NTA results showed that Exos of a diameter of about 100 nm with the round and oval vesicle-like structure were successfully extracted. The expressions of the CD63, CD81, and TSG101 proteins were positive in these Exos. After MSC-Exo treatment, the colon length in colitis mice increased; colon inflammatory injury decreased; TNF-α, IL-6, IL-1β, IL-17, and IL-18 levels decreased; and Claudin-1, ZO-1, and IκB levels increased. In addition, the structure of the gut microbiota in DSS-induced colitis mice was changed by MSC-Exos. MSC-Exos showed antiapoptotic effects on LPS-induced HCOEPIC. The protective effects decreased significantly by treatment with MSC-Exos interfered with miR-181a inhibitor and . MSC-derived exosomal miR-181a could alleviate experimental colitis by promoting intestinal barrier function. It exerted anti-inflammatory function and affected the gut microbiota. This indicated that MSC exosomal miR-181a may exhibit potential as a disease-modifying drug for UC.

Citing Articles

Microbiota and Inflammatory Markers: A Review of Their Interplay, Clinical Implications, and Metabolic Disorders.

Pena-Duran E, Garcia-Galindo J, Lopez-Murillo L, Huerta-Huerta A, Balleza-Alejandri L, Beltran-Ramirez A Int J Mol Sci. 2025; 26(4).

PMID: 40004236 PMC: 11854938. DOI: 10.3390/ijms26041773.


Hidden Partner of Immunity: Microbiome as an Innovative Companion in Immunotherapy.

Kim P, Joe S, Kim H, Jeong H, Park S, Song J Int J Mol Sci. 2025; 26(2).

PMID: 39859572 PMC: 11765694. DOI: 10.3390/ijms26020856.


Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date.

Giammona A, Galuzzi B, Imperia E, Gervasoni C, Remedia S, Restaneo L Int J Mol Sci. 2025; 26(1.

PMID: 39796266 PMC: 11720538. DOI: 10.3390/ijms26010413.


Deciphering the role of host-gut microbiota crosstalk via diverse sources of extracellular vesicles in colorectal cancer.

Song Y, Shi M, Wang Y Mol Med. 2024; 30(1):200.

PMID: 39501131 PMC: 11536884. DOI: 10.1186/s10020-024-00976-8.


Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles: A focus on inflammatory bowel disease.

Clua-Ferre L, Suau R, Vano-Segarra I, Gines I, Serena C, Manye J Clin Transl Med. 2024; 14(11):e70075.

PMID: 39488745 PMC: 11531661. DOI: 10.1002/ctm2.70075.


References
1.
Volarevic V, Markovic B, Gazdic M, Volarevic A, Jovicic N, Arsenijevic N . Ethical and Safety Issues of Stem Cell-Based Therapy. Int J Med Sci. 2018; 15(1):36-45. PMC: 5765738. DOI: 10.7150/ijms.21666. View

2.
Li H, Chen X, Guan L, Qi Q, Shu G, Jiang Q . MiRNA-181a regulates adipogenesis by targeting tumor necrosis factor-α (TNF-α) in the porcine model. PLoS One. 2013; 8(10):e71568. PMC: 3787936. DOI: 10.1371/journal.pone.0071568. View

3.
. Withdrawn. Eur J Immunol. 2019; 54(1):e1848007. DOI: 10.1002/eji.201848007. View

4.
Furuse M, Sasaki H, Tsukita S . Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol. 1999; 147(4):891-903. PMC: 2156154. DOI: 10.1083/jcb.147.4.891. View

5.
Ungaro R, Mehandru S, Allen P, Peyrin-Biroulet L, Colombel J . Ulcerative colitis. Lancet. 2016; 389(10080):1756-1770. PMC: 6487890. DOI: 10.1016/S0140-6736(16)32126-2. View